SCHEMBL3207601

SCHEMBL3207601

Cc1ccc(S(=O)(=O)OCC2CN(C)c3cccc(-c4ccccc4Cl)c3O2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
TSHR P16473 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.36
VDR P11473 1/20 0.36
PTGIR P43119 2/20 0.35
TP53 P04637 1/20 0.33
PTGDR Q13258 2/20 0.33
GRM2 Q14416 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
LMNA P02545 1/20 0.32
KCNN4 O15554 1/20 0.32
KCNA3 P22001 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3195046 0.83 ALDH1A1 (0.37) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL3208378 0.83 CYP2D6 (0.45) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL7920376 0.82 HTR1A (0.41) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4224731 0.82 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL730472 0.81 PTGIR (0.46) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4621993 0.81 CA2 (0.43) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4621704 0.81 CA2 (0.43) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4962952 0.80 LMNA (0.44) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4960403 0.80 LMNA (0.44) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL3205941 0.76 NISCH (0.36) GRM2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF WYETH 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF HTR2C, HTR5A, NPY1R ALDH1A1 1164/4885CYP3A4 298/4885CYP2D6 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.